Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
ESC Heart Failure|August 4, 2017
Right ventricular temporal assist device for cardiac recompensationIsabell Yan, Hanno Grahn, Stefan Blankenberg, et al.European Journal of Heart Failure|February 4, 2022
Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause - the Cardiogenic Shock ScoreBenedikt N Beer, Jacob C Jentzer, Jessica Weimann, et al.Plos One|September 1, 2018
Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cellsKarsten Lücke, Isabell Yan, Sonja Krohn, et al.ESC Heart Failure|July 4, 2025
Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathyIsabell Yan, Zoe Möhring, Daniel Reichart, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signalingJudith Hoge, Isabell Yan, Nathalie Jänner, et al.Journal of Leukocyte Biology|November 13, 2015
ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responsesIsabell Yan, Jeanette Schwarz, Karsten Lücke, et al.Journal of Clinical Medicine|April 2, 2020
Patient Characteristics, Treatment and Outcome in Non-Ischemic vs. Ischemic Cardiogenic ShockBenedikt Schrage, Jessica Weimann, Salim Dabboura, et al.ESC Heart Failure|February 19, 2021
Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shockBenedikt Schrage, Peter Moritz Becher, Alina Goßling, et al.ESC Heart Failure|March 25, 2021
Sex differences in patients with cardiogenic shockIsabell Yan, Benedikt Schrage, Jessica Weimann, et al.Journal of the American Society of Nephrology : JASN|July 18, 2019
A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive CapacityJulia Hagenstein, Simon Melderis, Anna Nosko, et al.Pageof 2